This effect of compound 2 was strongly associated with the concomitant decrease in anti-apoptotic (IAP1, IAP2, and survivin), angiogenic (growth factors), and cancer invasiveness (matrix metalloproteinase-9, COX-2) modulating proteins. The gene discussed is PTGS2; the disease is cancer.